TOVX icon

Theriva Biologics
TOVX

Overview Fund Activity

24 hedge funds and large institutions have $452K invested in Theriva Biologics in 2023 Q4 according to their latest regulatory filings, with 6 funds opening new positions, 4 increasing their positions, 5 reducing their positions, and 3 closing their positions.

Holders
24
Holders Change
+3
Holders Change %
+14.29%
% of All Funds
0.35%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
6
Increased
4
Reduced
5
Closed
3
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

1
Citadel Advisors
1
Citadel Advisors
Florida
$24.9K
2
VF
2
Virtu Financial
New York
$17K
3
Jane Street
3
Jane Street
New York
$20.5K
4
LNC
4
Lincoln National Corp
Pennsylvania
$4.73K
5
Susquehanna International Group
5
Susquehanna International Group
Pennsylvania
$4.61K

Top Sellers

1
Vanguard Group
1
Vanguard Group
Pennsylvania
$158K
2
TSS
2
Two Sigma Securities
New York
$0
3
Fisher Asset Management
3
Fisher Asset Management
Washington
$0
4
BlackRock
4
BlackRock
New York
$81.7K
5
Fidelity Investments
5
Fidelity Investments
Massachusetts
$4
Name Market Value Shares Shares
Change 		Shares
Change %
JPMorgan Chase & Co
26
JPMorgan Chase & Co
New York
– – -15 Closed
Royal Bank of Canada
27
Royal Bank of Canada
Ontario, Canada
$0 7 – –
CFGS
28
Concourse Financial Group Securities
Alabama
– – – –
1
2